Palatin Technologies, Inc.
corporate_fare Company Profile
Palatin Technologies, Inc. (NASDAQ:PTN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 6 items for PTN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for PTN spans S-3, 10-Q, 10-K, DEF 14A.
Recent high-impact activity:
- Palatin Files $100M Shelf Registration While Carrying a Going-Concern Warning
- Palatin Posts $1.29 Per-Share Quarterly Loss as Cash Crunch Deepens
- Palatin Cash Falls to $3.7M as Quarterly Burn Triples; Going Concern Stands
- Palatin 10-K: Going-Concern Warning Despite Narrowed Loss and $13.2M Collaboration Revenue
- Palatin Flags Going-Concern Risk as Cash Dwindles to $7.5M
Financial Snapshot
Short Interest & Short Volume
7.36 days to coverFINRA reported short interest of 295,427 shares in PTN as of the October 30, 2026 settlement, a 11.1% decrease from the prior period — about 7.4 days to cover at its recent average daily volume. On November 20, 2026, 66.3% of PTN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for PTN, detected from its recent SEC filings.
New $100M Shelf Registered · Float Cap Limits Real Proceeds
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →